Skip to main content

5 Top Stock Gainers for Tuesday: Novocure, Makinac

Novocure, Moderna, B. Riley, Makinac and Novavax are five prominent rising stocks in Tuesday's trading.
  • Author:
  • Publish date:

Stocks finished mixed Tuesday, with the S&P reaching record intraday and closing highs, as Wall Street looked beyond an uptick in U.S. consumer inflation and health officials recommended a pause in the use of Johnson & Johnson's  (JNJ) - Get Johnson & Johnson Report coronavirus vaccine.

Here are some of the big movers in the stock market on Tuesday:

1. Novocure | Increase 50%

Shares of Novocure  (NVCR) - Get NovoCure Limited Report jumped after an independent data monitoring committee reviewed the Phase 3 trial of its lung cancer treatment candidate. The committee said the interim results of the trial of Novocure's tumor-treating fields should be accelerated.

2. Moderna | Increase 7.4%

Moderna  (MRNA) - Get Moderna Inc. Report advanced after the company's coronavirus vaccine started being used to inoculate people under 30 years of age in England. The jab was recommended as an alternative to the vaccine from AstraZeneca  (AZN) - Get AstraZeneca PLC Report.

Scroll to Continue

TheStreet Recommends

3. B. Riley Financial | Increase 14%

B. Riley Financial  (RILY) - Get B. Riley Financial Inc. Report advanced after the S&P Dow Jones Indices said the financial services company on Thursday would replace Michaels Cos.  (MIK) - Get Michaels Companies Inc Report in the S&P SmallCap 600. Apollo Global Management  (APO) - Get Apollo Global Management Inc. (New) Report is acquiring Michaels.

4. Mackinac Financial | Increase 61%

Mackinac Financial  (MFNC) - Get Mackinac Financial Corporation Report soared after Nicolet Bankshares  (NCBS) - Get Nicolet Bankshares, Inc. Report said it was acquiring the regional bank in a transaction valued at about $248 million. The deal is expected to close in the third quarter.

5. Novavax | Increase 11%

Shares of vaccine maker Novavax  (NVAX) - Get Novavax Inc. Report were climbing after the Centers for Disease Control and Prevention and the Food and Drug Administration said they were suspending use of Johnson & Johnson's  (JNJ) - Get Johnson & Johnson Report coronavirus vaccine due to concerns about blood clotting. J&J shares were falling.